← United States · Coverage record
US · SEC FORM 4
PRO DEX INC
PDEX · Nasdaq · CIK 0000788920 · Healthcare · Medical Instruments & Supplies
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
26 Form 4 transaction lines observed in the same window
19 sales · 7 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-05-10 · Philp Katrina Marie Kramer.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 199,385
- Previous report
- 209,908
- Avg daily volume
- 68,882
- Days to cover
- 2.9
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2022-05-10 | Philp Katrina Marie Kramer | Purchase (P) | Common Stock | 3,900 | USD 14.98 | USD 58,422 | SEC filing ↗ |
| 2021-11-19 | Farrell William James III | Purchase (P) | Common Stock | 2,000 | USD 20.62 | USD 41,240 | SEC filing ↗ |
| 2021-09-13 | Philp Katrina Marie Kramer | Purchase (P) | Common Stock | 4,000 | USD 24.41 | USD 97,640 | SEC filing ↗ |
| 2021-09-13 | Philp Katrina Marie Kramer | Purchase (P) | Common Stock | 3,468 | USD 24.41 | USD 84,654 | SEC filing ↗ |
Form 4 evidence
40 transaction lines in the latest 365-day window; 142 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Van Kirk Richard Lee Jr | Sale (S) | Common Stock | 765 | USD 59.36 | USD 45,412 | SEC filing ↗ |
| 2026-09-09 | Van Kirk Richard Lee Jr | Sale (S) | Common Stock | 19,235 | USD 60.58 | USD 1,165,291 | SEC filing ↗ |
| 2026-09-09 | Charlton Alisha | Sale (S) | Common Stock | 2,300 | USD 61.30 | USD 140,983 | SEC filing ↗ |
Show recent Form 4 evidence (25 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Van Kirk Richard Lee Jr | Sale (S) | Common Stock | 765 | USD 59.36 | USD 45,412 | SEC filing ↗ |
| 2026-09-09 | Van Kirk Richard Lee Jr | Sale (S) | Common Stock | 19,235 | USD 60.58 | USD 1,165,291 | SEC filing ↗ |
| 2026-09-09 | Charlton Alisha | Sale (S) | Common Stock | 2,300 | USD 61.30 | USD 140,983 | SEC filing ↗ |
| 2026-07-23 | Domingo Angelita Rebamontan | Award / grant (A) | Common Stock | 19 | USD 33.25 | USD 632 | SEC filing ↗ |
| 2026-07-01 | Van Kirk Richard Lee Jr | Tax withholding (F) | Common Stock | 5,279 | USD 62.74 | USD 331,204 | SEC filing ↗ |
| 2026-07-01 | Van Kirk Richard Lee Jr | Award / grant (A) | Common Stock | 14,800 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-01 | Domingo Angelita Rebamontan | Tax withholding (F) | Common Stock | 2,488 | USD 62.74 | USD 156,097 | SEC filing ↗ |
| 2026-07-01 | Domingo Angelita Rebamontan | Award / grant (A) | Common Stock | 6,800 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-01 | Charlton Alisha | Tax withholding (F) | Common Stock | 3,897 | USD 62.74 | USD 244,498 | SEC filing ↗ |
| 2026-07-01 | Charlton Alisha | Award / grant (A) | Common Stock | 10,800 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-22 | Van Kirk Richard Lee Jr | Sale (S) | Common Stock | 4,128 | USD 62.36 | USD 257,438 | SEC filing ↗ |
| 2026-05-21 | Van Kirk Richard Lee Jr | Sale (S) | Common Stock | 5,872 | USD 62.81 | USD 368,810 | SEC filing ↗ |
| 2026-03-16 | Domingo Angelita Rebamontan | Sale (S) | Common Stock | 998 | USD 47.24 | USD 47,146 | SEC filing ↗ |
| 2026-01-22 | Domingo Angelita Rebamontan | Award / grant (A) | Common Stock | 18 | USD 34.36 | USD 618 | SEC filing ↗ |
| 2025-11-21 | Philp Katrina Marie Kramer | Award / grant (A) | Common Stock | 3,100 | USD 32.71 | USD 101,397 | SEC filing ↗ |
| 2025-11-20 | Van Kirk Richard Lee Jr | Tax withholding (F) | Common Stock | 72 | USD 30.83 | USD 2,220 | SEC filing ↗ |
| 2025-11-20 | Swenson Nicholas John | Award / grant (A) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-20 | Philp Katrina Marie Kramer | Award / grant (A) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-20 | HOVDA DAVID | Award / grant (A) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-20 | Farrell William James III | Award / grant (A) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-20 | Domingo Angelita Rebamontan | Tax withholding (F) | Common Stock | 72 | USD 30.83 | USD 2,220 | SEC filing ↗ |
| 2025-11-20 | Domingo Angelita Rebamontan | Award / grant (A) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-20 | Charlton Alisha | Tax withholding (F) | Common Stock | 72 | USD 30.83 | USD 2,220 | SEC filing ↗ |
| 2025-11-20 | Charlton Alisha | Award / grant (A) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-20 | CABILLOT RAYMOND E | Award / grant (A) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | PDEX |
| CIK | 0000788920 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 142 transaction lines from 2020-01-30 to 2026-09-11 4 P purchase lines · 71 S sale lines · 67 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.